CFO.next {CFO} | R Documentation |
Determination of the dose level for next cohort in the calibration-free odds (CFO) design
Description
In the CFO design, the function is used to determine the dose movement based on the toxicity outcomes of the enrolled cohorts.
Usage
CFO.next(target, cys, cns, currdose,
prior.para = list(alp.prior = target, bet.prior = 1 - target),
cutoff.eli = 0.95, early.stop = 0.95)
Arguments
target |
the target DLT rate. |
cys |
the cumulative numbers of DLTs observed at the left, current, and right dose levels. |
cns |
the cumulative numbers of patients treated at the left, current, and right dose levels. |
currdose |
the current dose level. |
prior.para |
the prior parameters for a beta distribution, where set as |
cutoff.eli |
the cutoff to eliminate overly toxic doses for safety. We recommend
the default value of |
early.stop |
the threshold value for early stopping. The default value |
Details
The CFO design determines the dose level for the next cohort by assessing evidence from the current
dose level and its adjacent levels. This evaluation is based on odds ratios denoted as O_k
, where
k = L, C, R
represents left, current (central), and right dose levels. Additionally, we define \overline{O}_k = 1/O_k
.
The ratio O_C / \overline{O}_{L}
indicates the inclination for de-escalation, while \overline{O}_C / O_R
quantifies the tendency for escalation. Threshold values \gamma_L
and \gamma_R
are chosen to
minimize the probability of making incorrect decisions. The decision process is summarized in Table 1
of Jin and Yin (2022).
The early stopping and dose elimination rules are implemented to ensure patient safety. If the data suggest excessive
toxicity at the current dose level, we exclude that dose level and those higher levels. If the lowest dose level is overly toxic,
the trial will be terminated according to the early stopping rule.
Value
The CFO.next()
function returns a list object comprising the following elements:
target: the target DLT rate.
cys: the cumulative counts of DLTs observed at the left, current, and right dose levels.
cns: the cumulative counts of patients treated at the left, current, and right dose levels.
decision: the decision in the CFO design, where
left
,stay
, andright
represent the movement directions, andstop
indicates stopping the experiment.currdose: the current dose level.
nextdose: the recommended dose level for the next cohort.
nextdose = 99
indicates that the trial is terminated due to early stopping.overtox: the situation regarding which positions experience over-toxicity. The dose level indicated by
overtox
and all the dose levels above experience over-toxicity.overtox = NA
signifies that the occurrence of over-toxicity did not happen.toxprob: the expected toxicity probability,
Pr(p_k > \phi | x_k, m_k)
, at the left, current, and right dose levels, wherep_k
,x_k
, andm_k
is the dose-limiting toxicity (DLT) rate, the numbers of observed DLTs, and the numbers of patients at dose levelk
.
Note
When the current dose level is the lowest or highest (i.e., at the boundary), the parts in cys
,
cns
, and toxprob
where there is no data are filled with NA
.
The dose level indicated by overtox
and all the dose levels above experience over-toxicity, and these dose levels will be eliminated.
Author(s)
Jialu Fang, Wenliang Wang, and Guosheng Yin
References
Jin H, Yin G (2022). CFO: Calibration-free odds design for phase I/II clinical trials. Statistical Methods in Medical Research, 31(6), 1051-1066.
Examples
## determine the dose level for the next cohort of new patients
cys <- c(0, 1, 0); cns <- c(3, 6, 0)
decision <- CFO.next(target=0.2, cys=cys, cns=cns, currdose=3)
summary(decision)
cys <- c(NA, 3, 0); cns <- c(NA, 3, 0)
decision <- CFO.next(target=0.2, cys=cys, cns=cns, currdose=1)
summary(decision)
cys <- c(0, 3, NA); cns <- c(3, 3, NA)
decision <- CFO.next(target=0.2, cys=cys, cns=cns, currdose=7)
summary(decision)